How Do Our Genes Sculpt a Heart?
As the first part of the Newton Webinar Series, Benoit Bruneau, PhD, director of the Gladstone Institute of Cardiovascular Disease had an intimate conversation with Robert Wicks, vice president of philanthropy at Gladstone.
Benoit shared how his lab is working to better understand the role genes play in building a heart and the code guiding the process. He also explored congenital heart defects, how they develop, what can be done to stop them before they start, and the implications for other cardiovascular diseases.
The Newton Webinar Series is inspired by the story of Isaac Newton’s extraordinary intellectual output while in quarantine during the Great London Plague of 1665, and offers an alternative to all the news related to COVID-19. Each week, we will feature a conversation with Gladstone’s scientists and explore their moonshot ideas, how they approach their work, and what they think medicine may look like 10, 20, and 50 years from now.
Up Next
Disrupted Boundary Between Cell Types Linked to Common Heart Defects
Gladstone scientists identified a cellular boundary that guides heart development and revealed how disrupting it can lead to holes in the heart’s wall.
CIRM Awards $7.5 Million in Discovery Grants to Gladstone Investigators
Two ambitious research projects led by Gladstone investigators are boosted by funds from the California Institute for Regenerative Medicine.
Matters of the Heart: A Conversation with Gladstone’s Benoit Bruneau
Bruneau, director of the Gladstone Institute of Cardiovascular Disease, shares exciting recent advances in heart research and talks about the impact of predictive AI.
Meet Gladstone: Emily Bulger
Graduate Student Emily Bulger describes her work in the Bruneau Lab, her family roots in science, and the scientist she'd like to have a conversation with
Get Involved
Join the Team
Our people are our most important asset. We offer a wide array of career opportunities both in our administrative offices and in our labs.
Open PositionsPartner With Us
Discoveries don’t stay in our labs. Gladstone facilitates spinout companies to advance promising therapies, shortening the path between scientific discovery and helping real patients.
Learn MoreGive
Your gift to Gladstone will allow our researchers to pursue high-quality science, focus on disease, and train the next generation of scientific thought leaders.
Donate Now